Cargando…

Modification of Cɛ mRNA Expression by EBV-Encoded Latent Membrane Protein 1

To evaluate the effect of expression of latent membrane protein (LMP) 1 encoded by Epstein-Barr virus (EBV) on Cɛ mRNA expression, mRNA levels were examined by RT-PCR or Northern blot analysis upon transient transfection of LMP1 in the splenocytes derived from Brown-Norway rats with or without immun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanashiro, Kazuhiko, Ohta, Shigeto, Sunagawa, Masanori, Nakamura, Mariko, Suzuki, Mikio, Kosugi, Tadayoshi
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2006
Materias:	Research Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1775027/ https://www.ncbi.nlm.nih.gov/pubmed/17392589 http://dx.doi.org/10.1155/MI/2006/68069

Ejemplares similares

Azelastine and suplatast shorten the distribution half-life of IgE in rats.
por: Hanashiro, Kazuhiko, et al.
Publicado: (2002)

Analysis of IgE turnover in non-sensitized and sensitized rats.
por: Hanashiro, K, et al.
Publicado: (2001)

The role of EBV-encoded miRNA in EBV-associated gastric cancer
por: Liu, Ting, et al.
Publicado: (2023)

The EBV-encoded Latent Membrane Proteins, LMP2A and LMP2B, Limit the Actions of Interferon by Targeting Interferon Receptors for Degradation
por: Shah, Khilan M., et al.
Publicado: (2009)

Epstein-Barr Viruses (EBVs) Deficient in EBV-Encoded RNAs Have Higher Levels of Latent Membrane Protein 2 RNA Expression in Lymphoblastoid Cell Lines and Efficiently Establish Persistent Infections in Humanized Mice
por: Gregorovic, Goran, et al.
Publicado: (2015)

Updates on Epstein–Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV
por: Ahmed, Naveed, et al.
Publicado: (2022)

Unexpected Instability of Family of Repeats (FR), the Critical cis-Acting Sequence Required for EBV Latent Infection, in EBV-BAC Systems
por: Kanda, Teru, et al.
Publicado: (2011)

Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignancies
por: Zhang, Chaoting, et al.
Publicado: (2021)

Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration
por: Endo, Kazuhira, et al.
Publicado: (2009)

Prognostic Significance of EBV Latent Membrane Protein 1 Expression in Lymphomas: Evidence from 15 Studies
por: Mao, Yuan, et al.
Publicado: (2013)

Human serum antibodies against EBV latent membrane protein 1 cross-react with α-synuclein
por: Woulfe, John, et al.
Publicado: (2016)

Latent membrane proteins from EBV differentially target cellular pathways to accelerate MYC-induced lymphomagenesis
por: Ikeda, Masato, et al.
Publicado: (2022)

Modification of EBV-Associated Pathologies and Immune Control by Coinfections
por: Münz, Christian
Publicado: (2021)

Establishment of Epstein–Barr Virus (EBV) Latent Gene-Expressing T-Cell Lines with an Expression Vector Harboring EBV Nuclear Antigen 1
por: Kanno, Hiroyuki, et al.
Publicado: (2023)

Overall avidity declines in TCR repertoires during latent CMV but not EBV infection
por: Couturaud, Barbara, et al.
Publicado: (2023)

Construction and Antiapoptosis Activities of Recombinant Adenoviral Expression Vector Carrying EBV Latent Membrane Protein 2A
por: Liu, Xishuang, et al.
Publicado: (2011)

Identification and characterization of novel B-cell epitopes within EBV latent membrane protein 2 (LMP2)
por: Xue, Xiangyang, et al.
Publicado: (2011)

Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells
por: Rancan, Chiara, et al.
Publicado: (2015)

Molecular Properties and Therapeutic Targeting of the EBV-Encoded Receptor BILF1
por: Knerr, Julius Maximilian, et al.
Publicado: (2021)

Emergence of CD4+ and CD8+ Polyfunctional T Cell Responses Against Immunodominant Lytic and Latent EBV Antigens in Children With Primary EBV Infection
por: Lam, Janice K. P., et al.
Publicado: (2018)

EBV-Encoded MicroRNA-BART17-3p Targets DDX3X and Promotes EBV Infection in EBV-Associated T/Natural Killer–Cell Lymphoproliferative Diseases
por: Jin, Jin, et al.
Publicado: (2023)

EBV-regulated global changes in mRNA isoform usage
por: Homa, Nicholas, et al.
Publicado: (2012)

BZLF1 interacts with chromatin remodelers promoting escape from latent infections with EBV
por: Schaeffner, Marisa, et al.
Publicado: (2019)

CXCR4 induces cell autophagy and maintains EBV latent infection in EBVaGC
por: Wang, Weiwen, et al.
Publicado: (2020)

Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL)
por: Bahri, Racha, et al.
Publicado: (2022)

Genetic variability and mutation of Epstein‒Barr virus (EBV)-encoded LMP-1 and BHRF-1 genes in EBV-infected patients: identification of precise targets for development of personalized EBV vaccines
por: Wang, Yue, et al.
Publicado: (2023)

Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the STK39 Gene in B Cells Infected by EBV
por: Bazot, Quentin, et al.
Publicado: (2018)

Unveiling Another Missing Piece in EBV-Driven Lymphomagenesis: EBV-Encoded MicroRNAs Expression in EBER-Negative Burkitt Lymphoma Cases
por: Mundo, Lucia, et al.
Publicado: (2017)

EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas
por: Khabir, Abdelmajid, et al.
Publicado: (2005)

EBV Latent Membrane Protein 1 Activates Akt, NFκB, and Stat3 in B Cell Lymphomas
por: Shair, Kathy H. Y, et al.
Publicado: (2007)

EBV latent membrane proteins promote hybrid epithelial-mesenchymal and extreme mesenchymal states of nasopharyngeal carcinoma cells for tumorigenicity
por: Zhu, Nannan, et al.
Publicado: (2021)

EBV latent membrane protein 1 augments γδ T cell cytotoxicity against nasopharyngeal carcinoma by induction of butyrophilin molecules
por: Liu, Yue, et al.
Publicado: (2023)

EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma
por: Li, Zhi, et al.
Publicado: (2015)

EBV‐encoded miRNAs target ATM‐mediated response in nasopharyngeal carcinoma
por: Lung, Raymond W‐M, et al.
Publicado: (2018)

SSTR2 in Nasopharyngeal Carcinoma: Relationship with Latent EBV Infection and Potential as a Therapeutic Target
por: Emanuel, Oscar, et al.
Publicado: (2021)

The Characteristics of Epstein‐Barr Virus (EBV)‐positive Diffuse Large B‐Cell Lymphoma: Comparison between EBV(+) and EBV(‐) Cases in Japanese Population
por: Kuze, Tetuo, et al.
Publicado: (2000)

Repositioning Antimicrobial Agent Pentamidine as a Disruptor of the Lateral Interactions of Transmembrane Domain 5 of EBV Latent Membrane Protein 1
por: Wang, Xiaohui, et al.
Publicado: (2012)

Epstein-Barr virus (EBV)–encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3
por: Iwakiri, Dai, et al.
Publicado: (2009)

Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas
por: Piccaluga, Pier Paolo, et al.
Publicado: (2015)

Tracking EBV-encoded RNAs (EBERs) from the nucleus to the excreted exosomes of B-lymphocytes
por: Ahmed, Waqar, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8h4914lh5j1c539e00smrfah4j